Latest & greatest articles for Metabolic Syndrome

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Metabolic Syndrome or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Metabolic Syndrome and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Metabolic Syndrome

1. Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study. (PubMed)

Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study. To investigate whether fenofibrate as add-on to statin treatment reduce persistent cardiovascular risk in adults with metabolic syndrome in a real world setting.Propensity matched cohort study.Population based cohort in Korea.29 771 adults with metabolic syndrome (≥40 years) receiving statin treatment. 2156 participants receiving combined treatment (statin plus fenofibrate (...) to be associated with the low risk of composite cardiovascular events with combined treatment.In this propensity weighted cohort study of adults with metabolic syndrome, the risk of major cardiovascular events was significantly lower with fenofibrate as add-on to statin treatment than with statin treatment alone.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

2019 BMJ

2. A systematic review and meta-analysis on the prevalence of cardiac autonomic neuropathy in prediabetes and metabolic syndrome

A systematic review and meta-analysis on the prevalence of cardiac autonomic neuropathy in prediabetes and metabolic syndrome Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

3. The effect of the combination of supervised physical activity or physical activity counselling and nutrition interventions on metabolic syndrome parameters in adults: a systematic review and meta-analysis of randomised control trials

The effect of the combination of supervised physical activity or physical activity counselling and nutrition interventions on metabolic syndrome parameters in adults: a systematic review and meta-analysis of randomised control trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO

4. Relationship between sleep duration and metabolic syndrome: a systematic review and meta-analysis

Relationship between sleep duration and metabolic syndrome: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

5. The effect of Chlorella Vulgaris on obesity related metabolic syndrome features: a systematic review of randomized controlled trials

The effect of Chlorella Vulgaris on obesity related metabolic syndrome features: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

6. Relationship between legumes consumption and metabolic syndrome: a meta-analysis of observational studies

Relationship between legumes consumption and metabolic syndrome: a meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

7. The risk of acute kidney injury in adult surgical patients with metabolic syndrome: a systematic review and meta-analysis

The risk of acute kidney injury in adult surgical patients with metabolic syndrome: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

8. Glycemic index, glycemic load and risk of metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies

Glycemic index, glycemic load and risk of metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

9. Carbohydrates intake and risk of metabolic syndrome: a meta-analysis of healthy people

Carbohydrates intake and risk of metabolic syndrome: a meta-analysis of healthy people Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

10. Breast cancer risk associated with glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes, prediabetes, obesity and metabolic syndrome: a systematic review

Breast cancer risk associated with glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes, prediabetes, obesity and metabolic syndrome: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

11. Effect of whey protein on metabolic syndrome components: a systematic review and meta analysis

Effect of whey protein on metabolic syndrome components: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

12. Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials

Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

13. Effectiveness of mobile health technologies assisting physical activity (PA) and lifestyle interventions to reduce cardiovascular risk indicators in metabolic syndrome patients: a systematic review and meta-analysis

Effectiveness of mobile health technologies assisting physical activity (PA) and lifestyle interventions to reduce cardiovascular risk indicators in metabolic syndrome patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO

14. Fecal microbiota transplantation for metabolic syndrome and obesity: a systematic review and meta-analysis

Fecal microbiota transplantation for metabolic syndrome and obesity: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

15. Angiotensin-(1-7) actions in animal models to study metabolic syndrome: a systematic review

Angiotensin-(1-7) actions in animal models to study metabolic syndrome: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

16. The effect of promoting the Mediterranean diet on metabolic syndrome, its components and related comorbidities in adults: a systematic review of controlled trials

The effect of promoting the Mediterranean diet on metabolic syndrome, its components and related comorbidities in adults: a systematic review of controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

17. The association between burnout, vital exhaustion, the metabolic syndrome and type 2 diabetes mellitus: a systematic review and a meta-analysis

The association between burnout, vital exhaustion, the metabolic syndrome and type 2 diabetes mellitus: a systematic review and a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

18. Identify optimal cutoff points of anthropometric indicators for predicting cardiovascular risk factors and metabolic syndrome: a systematic review and meta-analysis

Identify optimal cutoff points of anthropometric indicators for predicting cardiovascular risk factors and metabolic syndrome: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

19. Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis

Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

20. Metabolic benefits of cranberry supplementation in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials

Metabolic benefits of cranberry supplementation in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO